Recent reports suggest that GLP-1 drugs could have a significant economic impact in 2025
Better known to the public by brand names such as Ozempic, Wegovy, Trulicity, Rybelsus, Victoza, Saxenda, and Mounjaro, these glucose-lowering medications, which were initially approved for the treatment of patients with type 2 diabetes, have made headlines recently thanks to their demonstrated effectiveness at treating obesity and helping people with or without diabetes lose weight
While shopping malls and commercial centres have emerged as preferred alternatives, offering climate-controlled environments, comfortable seating, and diverse activities, they impose significant restrictions through surveillance regimes and commercial imperatives, creating a paradoxical situation where youth are simultaneously welcomed as consumers but rejected as social beings
Any prolonged caloric deficit puts muscle at risk